Abstract
BackgroundThe recent Oral Surveillance study has raised concerns about major cardiovascular events and malignancies related to tofacitinib in older rheumatoid arthritis (RA) patients with cardiovascular risk factors.ObjectivesTo compare the incidence...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
